Dr. Charles S. Henry, MD, PA

Dr. Henry practices at New Light Endo (Close) in Houston, Texas.

Dr. Henry's NPI, 1245201995, was assigned on January 31, 2006. Dr. Henry graduated from McGovern Medical School in 1999. Dr. Henry holds Texas license L2315.

Dr. Henry's primary practice is New Light Endo (Close), at 7777 Southwest Fwy, Houston, TX 77074 in Harris County. The practice phone is (713) 541-0000.

Dr. Henry's primary practice is New Light Endo (Close) in Houston, Texas. Dr. Henry is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is Southwest Nephrology Associates. Dmand AI also links Dr. Henry to 1 more hospital, 5 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Henry practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Henry's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Henry is board certified in nephrology by the American Board of Internal Medicine. Dr. Henry is licensed in Texas.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Henry treats.

CMS data shows 1,901 Medicare services from Dr. Henry across 12 procedure codes in 2024, for 382 Medicare patients. Medicare paid $154,217 for them.

CMS counts 382 Medicare patients who saw Dr. Henry in 2024. The largest group is 75 to 84, with 151 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 19% are also on Medicaid. Their average risk score is 3.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Henry's median patient age at 75, with 46% women.

In 2024, Dr. Henry wrote 1,717 Medicare Part D claims for 330 patients. 66% of them were for generic drugs. CMS names the drug for 1,483 of them, across 32 drugs with 11 or more claims each, at $635,957 in total drug cost. In 2023, CMS named 1,363 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Henry for performance year 2024, reported as part of a group. Dr. Henry accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 382 general payments to Dr. Henry from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $999.

Dr. Henry graduated from McGovern Medical School in 1999.

Dr. Henry is in network with 19 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.